Sézary syndrome (SS) is a leukemic variant of cutaneous T cell lymphoma (CTCL), and the
neoplastic CD4+ T cells of SS patients undergo intense clonal proliferation. Although Sézary …

Sézary syndrome (SS) represents a subtype of cutaneous T-cell lymphoma characterized by
the presence of a malignant CD4+ T-cell clone that accumulates mainly in the skin and …

The diverse aspects of cutaneous T-cell lymphomas may impede the diagnosis of Sézary
syndrome (SS) and mycosis fungoides (MF), in particular, at early stages of the disease. We …

Sézary Syndrome (SS) is a primary cutaneous T-cell lymphoma (CTCL) characterized by
erythroderma, lymphadenopathy and leukemic involvement of the peripheral blood. The …

Patients with Sézary syndrome (SS) show clonal expansion in the peripheral blood of skin‐
homing CD4+ T‐helper cells expressing cutaneous lymphocyte antigen (CLA). However, an …

BACKGROUND: Because there are currently many effective therapies available for Sézary
syndrome, close monitoring of disease progression is required in order for a clinician to …

Sézary syndrome (SS) is an aggressive leukemic form of cutaneous T-cell lymphoma with
neoplastic CD4+ T cells present in skin, lymph nodes, and blood. Despite advances in …

The expansion of CD4+ CD7–T cells in the peripheral blood of Sézary syndrome (SS) is well
known. It remains unclear whether this population contains the dominant T cell clone …

Sezary Syndrome (SS) is a rare and aggressive variant of Cutaneous T-Cell Lymphoma. It is
characterized by the co-presence of CD4+ neoplastic lymphocytes, named Sezary cells …

Sézary syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphoma
(CTCL) with a median life expectancy of less than 4 years. Although initial treatment …